NewEdge Advisors’s Ocugen OCGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$257K Buy
249,243
+12,063
+5% +$15.4K ﹤0.01% 2645
2026
Q2
$363K Buy
237,180
+70,585
+42% +$107K ﹤0.01% 2344
2026
Q1
$302K Buy
166,595
+31,135
+23% +$53.8K ﹤0.01% 2336
2025
Q4
$183K Buy
135,460
+55,305
+69% +$78.7K ﹤0.01% 2605
2025
Q3
$131K Buy
80,155
+43,341
+118% +$48K ﹤0.01% 2512
2025
Q2
$35.7K Buy
36,814
+24,460
+198% +$20.3K ﹤0.01% 2765
2025
Q1
$8.73K Buy
12,354
+12,350
+308,750% +$8.54K ﹤0.01% 3148
2024
Q4
$3 Buy
+4
New +$4 ﹤0.01% 3889
2024
Q3
– Sell
-317
Closed -$491 – 3906
2024
Q2
$491 Hold
317
– – ﹤0.01% 3570
2024
Q1
$520 Hold
317
– – ﹤0.01% 3581
2023
Q4
$182 Hold
317
– – ﹤0.01% 3611
2023
Q3
$127 Buy
+317
New +$157 ﹤0.01% 3353

Other funds holding OCGN

NewEdge Advisors's OCGN Position: Q3 2026 in Review

NewEdge Advisors increased its Ocugen (OCGN) stake by 5.1% in Q3 2026, buying an estimated $15.4K and bringing the position to 249,243 shares worth $257K. The position accounts for ﹤0.01% of the portfolio, ranked #2645.

NewEdge Advisors first reported a position in OCGN in Q3 2023 and has held it in 12 quarters since. The position peaked at $363K in Q2 2026. 107 funds tracked by Wall St. Rank hold OCGN as of Q3 2026.

  • NewEdge Advisors held 249,243 shares of Ocugen worth $257K as of Q3 2026.
  • NewEdge Advisors bought 12,063 Ocugen shares in Q3 2026, an estimated $15.4K.
  • Ocugen made up ﹤0.01% of NewEdge Advisors's portfolio in Q3 2026, its #2645 holding.
  • NewEdge Advisors first reported a position in Ocugen in Q3 2023 and has held it in 12 quarters since.
  • NewEdge Advisors's Ocugen position peaked at $363K in Q2 2026.
  • 107 funds tracked by Wall St. Rank held Ocugen as of Q3 2026.

Based on NewEdge Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.